Haemophilus influenzae colonizes the respiratory tract in humans and causes both invasive and noninvasive infections. As a threat to treatment, resistance against critically important antibiotics is on the rise in H. influenzae. Identifying mechanisms for horizontal acquisition of resistance genes is important to understand how multidrug resistance develops. The present study explores the antimicrobial resistance genes and their context in beta-lactam-resistant H. influenzae with coresistance to up to four non-beta-lactam groups. The results reveal that this organism is capable of acquiring resistance to a wide range of commonly used antibiotics through conjugative transfer of mobile genetic elements and transformation of chromosomal genes, resulting in mosaic genes with a broader resistance spectrum. Strains with chromosomally mediated resistance to extended-spectrum cephalosporins, co-trimoxazole, and quinolones combined with mobile genetic elements carrying genes mediating resistance to ampicillin, tetracyclines, and chloramphenicol have been reported, and further dissemination of such strains represents a particular concern.
KEYWORDS: Haemophilus influenzae, integrative conjugative element, multidrug resistant, horizontal gene transfer, PBP3, beta-lactam resistance, mobile genetic element
ABSTRACT
Haemophilus influenzae colonizes the respiratory tract in humans and causes both invasive and noninvasive infections. Resistance to extended-spectrum cephalosporins in H. influenzae is rare in Europe. In this study, we defined acquired resistance gene loci and ftsI mutations in multidrug-resistant (MDR) and/or PBP3-mediated beta-lactam-resistant (rPBP3) H. influenzae strains, intending to understand the mode of spread of antibiotic resistance determinants in this species. Horizontal transfer of mobile genetic elements and transformation with resistance-conferring ftsI alleles were contributory. We found one small plasmid and three novel integrative conjugative elements (ICEs) which carry different combinations of resistance genes. Demonstration of transfer and/or ICE circular forms showed that the ICEs are functional. Two extensively MDR genetically unrelated H. influenzae strains (F and G) from the same geographical region shared an identical novel MDR ICE (Tn6686) harboring blaTEM-1, catA2-like, and tet(B). The first Nordic case of MDR H. influenzae septicemia, strain 0, originating from the same geographical area as these strains, had a similar resistance pattern but contained another ICE [Tn6687 with blaTEM-1, catP and tet(B)] with an overall structure quite similar to that of Tn6686. Comparison of the complete ftsI genes among rPBP3 strains revealed that the entire gene or certain regions of it are identical in genetically unrelated strains, indicating horizontal gene transfer. Our findings illustrate that H. influenzae is capable of acquiring resistance against a wide range of commonly used antibiotics through horizontal gene transfer, in terms of conjugative transfer of ICEs and transformation of chromosomal genes.
IMPORTANCE Haemophilus influenzae colonizes the respiratory tract in humans and causes both invasive and noninvasive infections. As a threat to treatment, resistance against critically important antibiotics is on the rise in H. influenzae. Identifying mechanisms for horizontal acquisition of resistance genes is important to understand how multidrug resistance develops. The present study explores the antimicrobial resistance genes and their context in beta-lactam-resistant H. influenzae with coresistance to up to four non-beta-lactam groups. The results reveal that this organism is capable of acquiring resistance to a wide range of commonly used antibiotics through conjugative transfer of mobile genetic elements and transformation of chromosomal genes, resulting in mosaic genes with a broader resistance spectrum. Strains with chromosomally mediated resistance to extended-spectrum cephalosporins, co-trimoxazole, and quinolones combined with mobile genetic elements carrying genes mediating resistance to ampicillin, tetracyclines, and chloramphenicol have been reported, and further dissemination of such strains represents a particular concern.
INTRODUCTION
Haemophilus influenzae colonizes the respiratory tract in humans and causes both invasive and noninvasive infections. The most common type of H. influenzae that caused invasive infections used to be encapsulated strains that belonged to serotype b (Hib). After the commencement of vaccination against Hib, the overall incidence of invasive infections has decreased considerably, and invasive infections due to other serotypes (a and f) and noncapsulated strains (nontypeable; NTHi) have emerged (1).
As a threat to treatment, resistance against critically important antibiotics is on the rise in H. influenzae (2, 3). Beta-lactamase-producing strains emerged and increased rapidly in the 1970s, effectively eliminating traditional first-choice beta-lactamase-susceptible penicillins as safe options for empirical therapy. The most common horizontally acquired beta-lactamase gene in H. influenzae is blaTEM-1, originating from Escherichia coli (4). Acquisition of genes encoding extended-spectrum beta-lactamases (ESBLs) is reported for Haemophilus parainfluenzae (blaTEM-15) (5) but not yet for H. influenzae.
Horizontal gene transfer (HGT) of blaTEM-1 in H. influenzae is facilitated by small nonconjugative plasmids in a small proportion of isolates (6, 7), but the gene is more frequently transferred by integrative conjugative elements (ICEs) (8). In addition to blaTEM-1, ICEs may carry genes mediating resistance to chloramphenicol (cat, encoding chloramphenicol acetyltransferase) (9) and tetracyclines [tet(B), encoding efflux of tetracycline from the bacterial cell] (10). The first Nordic case of septicemia caused by a multidrug-resistant (MDR) H. influenzae with this phenotype was reported in 1983 (11).
ICEs are major effectors in genome dynamics in bacteria, being the most abundant conjugative elements in prokaryotes (12). They are self-transmissible mobile genetic elements (MGEs) that encode an apparatus for their own excision from the donor chromosome, subsequent circularization, conjugation, and reintegration into the recipient chromosome (13). ICEs often contain site-specific integrases which help the ICE to recombine at specific attachment (att) sites (14).
Genes involved in excision/integration and conjugation are clustered into distinct modules in the ICEs. In H. influenzae, ICEs harbor both an excisase and an integrase in their integration module, and their conjugation module consists of a conserved cluster of 24 genes constituting a particular lineage of type IV secretion systems (T4SSs) (15). The T4SS gene cluster encodes both proteins involved in DNA processing and transfer (relaxase and coupling protein being the two main parts) and mating pair formation (secretion channel, motor proteins, and retraction pilus/surface adhesin) (16).
Since 2000, chromosomal mechanisms conferring resistance to other classes of beta-lactams have become widespread in H. influenzae (2). The most important mechanism of non-beta-lactamase-mediated beta-lactam resistance in H. influenzae is altered penicillin-binding protein 3 (PBP3), which develops through spontaneous point mutations and/or transformation within the transpeptidase region of the ftsI gene (17). Resistance to extended-spectrum cephalosporins (ESC-R) is endemic in Japan and Korea (1). The ESC-R phenotype appears to develop stepwise along two distinct pathways, where a first stage substitution (N526K or R517H) is required for the acquisition of second stage (S385T) and third stage (L389F) substitutions (17, 18). This has given rise to a classification system for PBP3-mediated beta-lactam resistance (rPBP3) with six distinct resistance genotypes, denoted groups I, II, III, III-like, III+, and III-like+ (17, 19, 20).
There is strong evidence that resistance-conferring ftsI alleles could arise in vivo, either spontaneously or horizontally acquired by transformation. Several in vitro experiments have shown that complete or partial ftsI genes may be used to transform susceptible strains (17, 18, 21–23), and identical mutated ftsI alleles have been reported in genetically unrelated clinical strains (20, 24, 25). H. influenzae is naturally competent, with the ability to transform through DNA uptake and homologous recombination (26). Recognition and efficient DNA uptake depend on the presence of specific 9-bp uptake signal sequences (USS) in the donor molecule, with a 4-bp core being particularly important (27).
Transformation may also contribute to resistance to co-trimoxazole and quinolones, but the relative importance of this mechanism compared to that of spontaneous point mutations is, to our knowledge, incompletely investigated in H. influenzae. Resistance to co-trimoxazole is caused by reduced activity of trimethoprim due to alterations in the dfrA gene encoding dihydrofolate reductase (28) and/or resistance to sulfamethoxazole due to acquisition of sul genes or mutations in the folP gene encoding dihydropteroate synthase (29). Resistance to quinolones is usually due to substitutions in the quinolone resistance-determining regions of topoisomerase II (GyrA) and IV (ParC) (30). Whereas co-trimoxazole resistance is common, resistance to quinolones is still infrequent in most parts of the world. A notable exception is the emergence of levofloxacin-resistant H. influenzae clones in Taiwan (31).
Importantly, resistance to multiple classes of antibiotics may occur in the same strain through a combination of MGEs and chromosomal mechanisms, exemplified by the clonal expansion of ESC-R strains with blaTEM-1 and coresistance to ciprofloxacin, tetracycline, chloramphenicol, and co-trimoxazole in Norway (20).
In this study, we defined acquired resistance gene loci and ftsI mutations in Norwegian MDR and/or rPBP3 H. influenzae strains, with the aim to explore the mode of spread of antibiotic resistance determinants in this species through horizontal transfer of MGEs and transformation with resistance-conferring ftsI alleles.
RESULTS AND DISCUSSION
Analyses of the whole-genome sequencing (WGS) data confirmed that seven of the isolates in our collection had the acquired blaTEM-1 beta-lactam resistance gene, and five of these isolates had also acquired resistance genes to chloramphenicol (catA-like, catP) and tetracycline [tet(B)], which matched their phenotypic profiles (Table 1).
TABLE 1.
Strain or isolate | Reference | Yr of isolation | Site of origin | Phenotypic resistanceb |
WGS cladec | MLSTd |
Serotypee | PBP3 resistance |
ftsI typeh | Acquired resistance gene(s)i | Mobile genetic element | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beta-lactam(s) | Other agent(s) | CC | ST | Levelf | Groupf | Typeg | |||||||||
0 | 11 | 1983 | Blood | A | Te, Ch | VI | 6 | 119 | Hib | sPBP3 | sPBP3 | z | alpha-x | blaTEM-1, catP, tet(B) | Tn6687 |
A | 24 | 2007 | Ear | Cf | Tx | IV | 57 | 57 | NT | Low | II | A | lambda-2 | — | — |
B | 24 | 2007 | Npxj | Cf | — | V | 3 | 367 | NT | Low | II | A | lambda-2 | — | — |
C | 24 | 2007 | Ear | Cf | — | V | 12 | 12 | NT | Low | II | H | gamma | — | — |
D | 24 | 2007 | Npx | Cf | — | IV | 422 | 411 | NT | Low | II | H | gamma | — | — |
E | 20 | 2010 | Eye | A, Ac, Cf, Ct, Cx | Tx, Ci | IV | 422 | 422 | NT | High | III-like+ | 3 | ftsI-4 | blaTEM-1 | Tn6685 |
F | 20 | 2013 | Sputum | A, Ac, Cf, Ct, Cx | Tx, Te, Ch | II | 503 | 1282 | NT | High | III-like+ | 3 | ftsI-4 | blaTEM-1, catA-like, tet(B) | Tn6686 |
G | 20 | 2013 | Sputum | A, Ac, Cf, Ct, Cx | Tx, Te, Ch, Ci | II | 503 | 159 | NT | High | III+ | 2 | ftsI-5 | blaTEM-1, catA-like, tet(B) | Tn6686 |
G2 | 20 | 2013 | Eye | A, Ac, Cf, Ct, Cx | Tx, Te, Ch, Ci | II | 503 | 159 | NT | High | III+ | 2 | ftsI-5 | blaTEM-1, catA-like, tet(B) | Tn6686 |
G3 | 20 | 2013 | Npx | A, Ac, Cf, Ct, Cx | Tx, Te, Ch, Ci | II | 503 | 159 | NT | High | III+ | 2 | ftsI-5 | blaTEM-1, catA-like, tet(B) | Tn6686 |
H | 20 | 2013 | Npx | A, Ac, Cf, Ct, Cx | Tx | V | 245 | 836 | NT | High | III+ | 2 | ftsI-2 | blaTEM-1 | pHblaTEM-1 |
I | 20 | 2012 | Ear | A, Ac, Cf, Ct, Cx | — | I | 124 | 124 | Hif | High | III+ | 2 | ftsI-2 | — | — |
Shading indicates identical resistance-conferring ftsI alleles or MGE shared by different strains or isolates.
A, ampicillin; Ac, amoxicillin-clavulanic acid; Cf, cefuroxime; Ct, cefotaxime; Cx, ceftriaxone; Tx, co-trimoxazole; Te, tetracycline; Ch, chloramphenicol; Ci, ciprofloxacin; —, none. For MICs and clinical breakpoints, see Table S2 in the supplemental material.
Whole-genome phylogeny with assignment to phylogenetic groups according to De Chiara et al. (50).
MLST, multilocus sequence typing; CC, clonal complex (named after predicted founder by eBURST analysis); ST, sequence type.
Hib, serotype b; Hif, serotype f; NT, nontypeable.
Based on amino acid substitutions in penicillin-binding protein 3 (PBP3), positions 385, 389, 517, and 526. sPBP3, no substitutions; Low, N526K or R517H; High, S385T in addition to N526K or R517H; II, N526K; III-like+, S385T, L389F, R517H; III+, S385T, L389F, N526K (20, 24).
Based on amino acid sequences in positions 350, 357, 377, 385, 389, 502, 517, 526, 532, 547, 557, 562, and 569 (substitutions underlined): z, DSMSLARNTVYVN (identical to the reference sequence Rd KW20 [53]); A, NSISLVRKTIYVS; H, DSMSLVRKTVYVN; 3, NNITFAHNSIHVS; 2, NNITFARKTIYLS (20, 24).
Based on partial nucleotide sequences in the transpeptidase domain of the ftsI gene (nt 1010 to 1719) (20, 24). The ftsI type for strain 0 clusters with Rd KW20 in group alpha (24) and is therefore assigned alpha-x.
bla, beta-lactamase gene; catA and catP, chloramphenicol resistance genes; tet(B), tetracycline resistance gene; —, none.
Npx, nasopharynx.
ICEs and small plasmids have been described to house acquired resistance genes and mediate horizontal transfer of these genes in H. influenzae. Therefore, we looked more closely at the contigs containing the acquired resistance genes.
Strain H: plasmid with blaTEM-1.
In strain H, the blaTEM-1 gene was shown to be part of a contig with homology to small plasmids in H. influenzae and Haemophilus parainfluenzae (data not shown). Gap closure of the blaTEM-1 contig showed that the blaTEM-1 plasmid in strain H is identical to the small 5,142-bp H. influenzae plasmid pA1209 (data not shown), isolated from a patient in the Aarhus region in Denmark (6). This plasmid contained three open reading frames (ORFs): (i) an ORF encoding a replication protein of the Rep 3 superfamily typical of small resistance plasmids in Pasteurellaceae, (ii) the blaTEM-1 gene, and (iii) an ORF with partial identity to a plasmid recombination enzyme that may help the plasmid recombine into other replicons and thereby get mobilized. Mating was attempted using strain Rd-Rif as a recipient, but no transconjugants were found within the detection limit (<1 × 10−11 transconjugants/donor). This is not surprising, since strain H does not harbor all the genes necessary for conjugation, as determined by running the genome in the web-based bacterial type IV secretion system resource, SecReT4 (32).
Strain E: novel ICE (Tn6685) with blaTEM-1.
The blaTEM-1 gene in strain E was located within a novel 52.4-kb ICE (Tn6685) which is most similar to the previously described 53.0-kb ICEHin2866 (33) (Fig. 1). Tn6685 contains three ORFs that are not present in ICEHin2866. These encode a hypothetical protein and two products with conserved domains, indicating they belong to the type IV toxin-antitoxin system, part of the nucleotidyltransferase AbiEii superfamily. The AbiEii toxin and its cognate transcriptional regulator AbiEi antitoxin belong to abortive bacterial infection (Abi) systems. These can have a dual function, namely, (i) protecting bacteria from spread of a phage infection by aborting the cell upon phage infection, and (ii) ensuring stability of MGEs containing such toxin-antitoxin systems by killing cells that lose the MGE upon cell division (34).
Strains F and G: novel ICE (Tn6686) with blaTEM-1, catA2-like, and tet(B).
Strain F and three isolates of strain G (G, G2, and G3), isolated within a time span of 2 weeks from four patients living in the same geographical region (20) and belonging to the same clonal complex (CC-ST503), harbored identical acquired resistance genes against penicillins (blaTEM-1), chloramphenicol (catA-like; 90% identity to catA2 [GenBank accession number X53796]), and tetracycline [tet(B)]. Isolates G, G2, and G3 had the same multilocus sequence type (MLST) and phenotypic resistance pattern and identical ftsI gene, indicating they belong to the same strain. Core genome phylogeny supports that isolates G, G2, and G3 are very closely related: G has 13 and 12 single nucleotide polymorphisms (SNPs) in the core genome compared to G2 and G3, respectively, whereas G2 and G3 have only a two-SNP difference between them. Strain F showed a related ST with six of seven MLST alleles in common with strain G. However, strain F is not closely related to strain G, since it has 1,493 core SNP differences compared to strain G, a slightly different resistance pattern and a different PBP3 type than strain G.
Pairwise BLAST revealed the presence of large fragments of ICEHin1056 (GenBank accession number [acc. no.] AJ627386) (35) in all four isolates. This ICE encodes resistance to penicillins, chloramphenicol, and tetracycline. Gap closures revealed a 100% identical putative novel 64.7-kb ICE (Tn6686) in all four isolates belonging to strain F and strain G. The presence of an identical ICE in the two different strains as well as close epidemiological connection between strain F and G indicate that transfer of this ICE has occurred between these strains. The overall structure of Tn6686 is quite similar to that of ICEHin1056 (Fig. 2). This novel ICE has an inverted region around the catA-like gene due to IS5 elements and a complete Tn3 element, including the transposase gene that is missing in ICEHin1056. Tn6686 has some additional ORFs not present in ICEHin1056, including ORFs encoding a site-specific recombinase/DNA invertase homologue that is found in other ICEs of Haemophilus such as ICEHin2866 (Fig. 3) and Actinobacillus pleuropneumoniae ICEApl1, and a type I restriction modification system subunit M with 100% identity to methyltransferases found in other ICEs of Haemophilus (GenBank acc. no. ADO80528.1) and A. pleuropneumoniae (GenBank acc. no. ANC65583.1). However, the other subunits necessary for restriction modification function (36) are missing.
Strain 0: novel ICE (Tn6687) with blaTEM-1, catP and tet(B).
Strain 0 caused the first Nordic case of MDR H. influenzae septicemia (11) and originates from the same geographical area as strains F and G. As strains 0, F, and G have similar resistance patterns, except for the lack of ESC-R in strain 0 (sensitive PBP3 genotype/phenotype [sPBP3]) (Table 1), we were curious whether the much older strain 0 contains the same ICE as the novel Tn6686 found in strains F and G. However, the acquired resistance genes in strain 0 turned out to be different, as this strain contains catP rather than the catA-like gene found in strains F and G. Gap closure revealed that strain 0 contains a novel 68.8-kb ICE (Tn6687) containing blaTEM-1, catP, and tet(B). Comparisons of Tn6687 with Tn6685, Tn6686, and ICEHin2866 showed that Tn6687 is more similar to Tn6686 than to other ICEs previously described in H. influenzae (Fig. 2 and 3). The overall structure is also quite similar to Tn6686 except for some additional putative ORFs and that the cat gene regions are different and on opposite sides of the tet(B) region. The catP gene is surrounded by putative ORFs encoding a hypothetical protein with similarity to plasmid recombination proteins, an AAA family ATPase similar to the uncharacterized protein TnpY encoded by the mobilizable transposon Tn4451, and a TndX-like transposase, suggesting it is part of a smaller MGE. Moreover, Tn6687 contains a gltS gene encoding a sodium-glutamate symporter important for growth with glutamate as carbon and nitrogen sources (37).
Integration and transferability of novel ICEs.
ICEs are expected to circularize after excision (13). A circular form of the ICE was demonstrated in all isolates containing novel ICEs (strains E, F, G/G2/G3, and 0) by PCRs using primers directed outwards from the integrated ICE (see Fig. S1 in the supplemental material). Sequencing of the PCR products confirmed the expected joined right and left end sequences and determination of the correct ends of the ICEs (data not shown). These results demonstrate that the enzymes involved in excision of the ICEs are functional and indicate that the ICEs are potentially transferable.
All the novel ICEs have the highly conserved cluster of genes encoding T4SS products mediating conjugation (Fig. 1 and 3). Mating was attempted using strains E, F, G, and 0 as donors. ICEHin1056 transfer frequency was previously shown to range from 10−1 to 10−9 (33). Transconjugants were obtained and confirmed with strains F, G, and 0 as donors (transfer frequencies ranging from 5 × 10−7 to 6 × 10−9 transconjugants/donor), confirming that the novel ICEs in these strains are transferable. Transconjugants containing Tn6685 using strain E as donor were not obtainable.
Comparison of the integration sites and right and left ends of all the ICEs, including ICEHin1056, shows that the ICE ends and part of the integration sites are identical; thus, these ICEs integrate in a site-specific manner. All the ICEs are inserted downstream of the 22nd nucleotide in tRNA-Leu. The integration site tRNA-Leu appears in two copies in H. influenzae, in separate chromosomal locations. This explains why the chromosomal location of Tn6685 and Tn6687 is different from that of Tn6686 (Fig. 4).
HGT of resistance-conferring ftsI alleles.
Figure 5 shows the distribution of SNPs and substitutions in ftsI/PBP3 of strains A to I.
As reported previously (24), the genetically unrelated strains within each of the strain pairs A/B and C/D share identical ftsI alleles (lambda-2 and gamma, respectively). These strains, collected in 2007, are low-level resistant (group II rPBP3) and susceptible to ESC (Table 1). Comparison of complete ftsI genes revealed that the genes are identical in strains A and B, except for three mutations in the 3′ end of the gene in strain B leading to two additional amino acid substitutions (S594T and A595T), whereas strains C and D share completely identical ftsI genes (Fig. 5). Similarly, the genetically unrelated strains within each of the strain pairs E/F (group III-like+) and H/I (group III+) isolated between 2010 and 2013, all categorized as high rPBP3 and expressing the ESC-R phenotype, share identical ftsI types (ftsI-4 and ftsI-2, respectively), despite being genetically unrelated, as depicted by WGS and MLST phylogeny (Table 1) (20). However, the nucleotide sequences upstream of the STVK motif in the strain pairs E/F and H/I differ at 3 and 13 positions, respectively, indicating possible HGT with recombination affecting only the transpeptidase region of ftsI.
As shown in Fig. 5, a fragment of the transpeptidase region surrounding the SSN motif (green shading) was identical or highly similar in strains E, F, H, and I, as well as in strain G, which belongs to the same clonal complex as strain F but has a different MLST profile. Alignment of the SSN-near region (nucleotide [nt] 1006 to 1295) showed that the ftsI types carried by strains E to I (ftsI-2, ftsI-4, and ftsI-5) had a maximum one-SNP difference between them, while they differed from the reference sequence by 24 to 25 SNPs (<92% identity) (Table S1 and Fig. S2 and S3). This observation is of particular significance, as this region harbors the second- and third stage-substitutions S385T and L389F, with the potential to transform low-rPBP3 strains into high-rPBP3 strains (group III-like+ or III+), which in most cases will express resistance to ESC. Notably, ftsI-2, ftsI-4, or ftsI-5 was present in 12 of 16 isolates with high+ (group III-like+ or III+) genotypes in a previous report on the first 30 high-rPBP3 strains reported in Norway (20).
These findings not only support the generally accepted notion that HGT of mutant ftsI (complete or partial) contributes to the development of PBP3-mediated resistance in H. influenzae but also strongly indicate that low-rPBP3 strains may acquire second-stage and third-stage PBP3 substitutions through HGT of the SSN-near region as a single recombinational event. This is not surprising, as theoretically, this region may be more easily transferable through transformation than other parts of the ftsI gene due to the close proximity to the only complete USS in the gene (nt position 1006 to 1014) (Fig. 5, S3, and S4).
Interestingly, a large number of silent DNA mutations in the SSN-near region of ftsI-2, ftsI-4, and ftsI-5 were also present in the older lambda-2 (Fig. S3 and S4). The lambda-2 allele, encoding the widespread low-rPBP3 type IIA, was the most frequent resistance-conferring ftsI allele in Norway in 2007, present in 30% (35/116) of rPBP3 isolates, belonging to four unrelated STs (24).
We propose that the emergence of high-rPBP3 H. influenzae in Norway in 2006 to 2013 (20) started with the evolution of a distinct high-rPBP3-encoding SSN-near region from the corresponding region of low-rPBP3-encoding ftsI alleles belonging to the highly prevalent cluster lambda through acquisition of additional point mutations driven by antibiotic pressure. This fragment subsequently disseminated to various low-rPBP3 strains through HGT and transformed them into high-rPBP3 strains. It should be noted that the first high-rPBP3 strains emerged in Norway when the prevalence of low-rPBP3 strains reached 15% (20). This is strikingly similar to the development in Japan 1 decade earlier, when a shift from low-rPBP3 to high-rPBP3 strains occurred when the prevalence of low-rPBP3 strains was approximately 18% (38), suggesting that this level of low-level resistance represents a critical threshold for the development of high-rPBP3 strains in the presence of antibiotic selective pressure.
It should also be noted that strains E and F, carrying the novel ICEs Tn6685 and Tn6686, both possess one of two fourth-stage PBP3 substitutions (Y557) associated with high-level resistance to ESC (cefotaxime MIC, 8 to 16 mg/liter) when they occur concomitantly (25). Including strains E and F, four group III-like+ high-rPBP3 isolates with the Y557H substitution have been reported in Norway (20). Such strains are presumably at particular risk of developing high-level ESC resistance through acquisition of an additional fourth-stage substitution (G555E) (25).
Conclusion.
The findings in this study illustrate that H. influenzae is capable of acquiring resistance to a wide range of commonly used antibiotics through HGT, in terms of conjugative transfer of ICEs and transformation with chromosomal resistance genes resulting in mosaicism. To our best knowledge, strain G is still the most multidrug-resistant H. influenzae strain reported (20). In addition to the chromosomal and acquired resistance mechanisms present in strain G, transferable genes conferring resistance to macrolides (39), quinolones (40), and aminoglycosides (41), as well as tet(M)-mediated resistance to tetracyclines (42), have been reported in H. influenzae. The recently demonstrated potential for further resistance development to critically important beta-lactams such as ESC (25) and carbapenems (43) is a cause for concern. Strains with chromosomally mediated resistance to extended-spectrum cephalosporins, co-trimoxazole, and quinolones combined with MGEs carrying genes mediating resistance to ampicillin, tetracyclines, and chloramphenicol have already been reported, and dissemination of such strains represents a particular worry for the future.
MATERIALS AND METHODS
Bacterial isolates.
The included isolates (Table 1) were selected from previous studies (11, 20, 24) based on phenotypic and genotypic characteristics suggesting beta-lactam resistance acquired through HGT of MGE and/or mutant ftsI alleles. The strain pairs A/B, C/D, E/F, and H/I consist of genetically unrelated rPBP3 strains sharing identical mutated ftsI alleles (nt 1010 to 1719) encoding resistance-conferring PBP3 sequences (20, 24), whereas strain 0 (11) and strains E to H (20) are beta-lactamase positive, indicating horizontal acquisition of a bla gene.
Antimicrobial susceptibility testing.
Table 1 shows phenotypic resistance profiles based on MICs for selected clinically relevant beta-lactam and non-beta-lactam antibiotics, interpreted according to the most recent version of EUCAST clinical breakpoints (44). MICs were determined by broth microdilution (BMD) using custom Sensititre plates (NONAG7; TREK Diagnostic Systems, Thermo Scientific) and MH-F broth according to EUCAST recommendations (45). Strains 0 and A to D were tested at EUCAST Development Laboratory, Växjö, Sweden; strains E to I were tested at Vestfold Hospital Trust.
Bacterial isolates, DNA extraction, genome sequencing, and assembly.
The isolates were cultured on chocolate agar overnight, and a single colony was transferred to brain heart infusion (BHI) broth and grown overnight in a CO2 atmosphere. Genomic DNA was extracted using the Promega Wizard genomic DNA purification kit.
WGS of the study strains was conducted using MiSeq (isolates A to I) or NextSeq 500 (isolates G2, G3, and 0) (Illumina, San Diego, USA). A 2 × 250-bp paired-end library was prepared and sequenced using MiSeq (Illumina) paired-end technology. A library was prepared via the Nextera XT DNA library preparation kit (Illumina) and sequenced using NextSeq 500 and the Mid Output 300 cycles cell. This generated from 2.7 to 8.8 million reads that were trimmed using Trimmomatic (46), resulting in reads ranging from 2.4 to 8.6 million reads. Trimmed reads were assembled with SPAdes 3.10.1 (47). Contigs below 2× coverage and with a length shorter than 200 bp were removed using in-house scripts.
Phylogenetic grouping of the strains and single nucleotide polymorphism analyses of isolates within strain G.
In silico multilocus sequence typing was performed with the MLST tool at the Center for Genomic Epidemiology webpage (48). Individual sequence types were assigned to clonal complexes (CC), defined by the predicted founder, using eBURSTv3 (http://haemophilus.mlst.net/eburst/). Phylogroups were determined by construction of a core genome multialignment by Parsnp (49) using the WGS sequences of our isolates together with those of a reference material (50), reconstruction of a phylogenetic tree by FastTree2 (51), and phylogenetic grouping according to De Chiara et al. (50). Core genome SNPs were called using Snippy 4.3.6 (https://github.com/tseemann/snippy) with strain G as the reference.
ftsI/PBP3 genotyping.
Assignment to PBP3 groups, PBP3 types, and ftsI types (Table 1) was performed according to the classification system used in the original publications (20, 24). In short, a 710-bp fragment of the transpeptidase region of ftsI (nt 1010 to 1719) was used to define unique ftsI types and PBP3 types, whereas PBP3 grouping was based on the presence of amino acid substitutions in positions 385, 389, 517, and 526, as suggested previously (17, 19, 20).
Mapping of ftsI SNPs and amino acid substitutions in PBP3 of strains A to I was performed and drawn using the tool Easyfig (52) and later edited with Inkscape 0.92.2. Conserved motifs of particular importance for transpeptidase function (327-STVK, 379-SSN, and 512-KTG) as well as complete 9-bp USS and partial USS with the critical 4-bp core (27) in the reference sequence Rd KW20 (53) were plotted against the sequences of the study strains (Fig. 5 and Fig. S4 in the supplemental material).
In-detail analyses of the SSN-near region were conducted using tools and software available online at http://www.phylogeny.fr (Fig. S2) and https://www.ebi.ac.uk (Fig. S3).
Bioinformatic analyses to confirm resistance genes and map sequences to MGEs.
Acquired resistance genes were identified using ResFinder with 90% threshold and 60% minimum length (54). Plasmid and ICE structure was found by Basic Local Alignment Search Tool (https://blast.ncbi.nlm.nih.gov/Blast.cgi) and mapping to appropriate sequences. Pairwise comparisons were displayed by Artemis comparison tool (55) using files generated by BLASTn (56). Figures were drawn using Easyfig and edited with Inkscape. ICEs/genomes were annotated with prokka v.1.12 (57).
Conjugative transfer of ICEs.
A rifampin-resistant spontaneous mutant of H. influenzae Rd (CCUG 18800) made by plating on chocolate agar with 10 mg/liter rifampin was used as recipient strain (Rd-Rif). Filter mating was performed using the following modifications of the method described by Juhas et al. (15). The isolates were grown 48 h on chocolate agar before approximately 108 cells were scraped off the plate and resuspended in 1 ml BHI broth. One hundred microliters of donor cell suspension was gently mixed with 100 μl recipient cell suspension before the mixture was spread at the center of antibiotic-free chocolate plates. Recipient and transconjugants were selected on agar plates containing rifampin (10 mg/liter) for recipients or rifampin (10 mg/liter) plus tetracycline (12 mg/liter) or ampicillin (4 mg/liter) for transconjugants.
Gap closure, circularization of ICEs, and confirmation of transconjugants.
DNA extraction was performed using NucliSens EasyMAG instrument and reagents (bioMérieux, Marcy-l’Etoile, France) according to the manufacturer’s instructions. JumpStart REDTaq ReadyMix (Merck KGaA, Darmstadt, Germany) was used for PCRs, and BigDye 3.1 technology (Applied Biosystems, Waltham, MA) was used for Sanger sequencing.
Contig gap closure was performed by PCR and Sanger sequencing. A circular form of ICEs was demonstrated by sequencing of PCR products obtained using primers directed outwards from the ends of the ICE (Fig. S1). Transconjugants were confirmed by PCRs specific for the ICE (blaTEM) and for the recipient (Rd217) (Table 2).
TABLE 2.
Circularization ICE | Sequence (5′→3′) |
Product size (bp) | Reference | |
---|---|---|---|---|
Forward primer | Reverse primer | |||
Tn6685 inverse | GCGTTAGTGGATCGATCGTAG | CACGACGGGTTAAAAACTCA | 508 | This study |
Tn6686 inverse | CGTAATGTTTGTATCAGCCTTTTT | GTTCTTAAACCGTGGTCAGC | 700 | This study |
Plasmid gap closure | ||||
pHblaTEM 1 | TAGCTTCCCGGCAACAATTA | AGCGAAATATCTGGGCTGAA | ca. 400 | This study |
pHblaTEM 2 | CCCAGATATTTCGCTCTTTCC | TTGTGGGCTGAGTTACAACG | ca. 450 | This study |
PCRs to confirm transconjugants | ||||
TEM PCR to detect ICE gene blaTEM-1 | ATGAGTATTCAACATTTCCG | CCAATGCTTAATCAGTGAGG | 858 | 58 |
Rd217 (Rd-ORF specific PCR) | TCTAATTATCGGCGCGATTT | TCACATCACGATGGAAGGAA | 463 | This study |
Data availability.
The whole-genome sequences of the isolates have been deposited in GenBank under BioProject number PRJNA557131. The novel ICE element sequences have been deposited in GenBank under the accession numbers MN106410 to MN106412.
ACKNOWLEDGMENTS
We thank Einar Vik at Molde Hospital and Martin Steinbakk at the Norwegian Institute of Public Health for providing strain 0, and the microbiological departments at Akershus University Hospital, University Hospital of North-Norway, Vestre Viken Hospital Trust, Stavanger University Hospital, Haukeland University Hospital, and Vestfold Hospital Trust for contributing with isolates A to I. We also thank Tracy M. Lunde and Martin O. K. Christensen at Norwegian National Advisory Unit on Detection of Antimicrobial Resistance, and Marianne Odnakk Ludahl, Inger Lill Anthonisen, Mette Lundstrøm Dahl, Kanita Pimpaporn, and Anita Bratfoss Andreassen at Vestfold Hospital Trust for excellent technical assistance, as well as Seila Pandur at Institute for Chemistry, Center for Bioinformatics, UiT—The Arctic University of Norway, for genome sequencing of the MiSeq data and Hagar Taman at the Genomics Support Center Tromsø, for genome sequencing using NextSeq500. We thank Erika Matuschek and the staff at EUCAST Development Laboratory for conducting BMD MIC determination for strain 0 and strains A to D free of charge.
The contribution of Dagfinn Skaare was partly funded by a research grant from the South-Eastern Norway Regional Health Authority project number 2016132. The publication charges for this article have been funded by a grant from the publication fund of UiT—The Arctic University of Norway. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
REFERENCES
- 1.Van Eldere J, Slack MPE, Ladhani S, Cripps AW. 2014. Non-typeable Haemophilus influenzae, an under-recognised pathogen. Lancet Infect Dis 14:1281–1292. doi: 10.1016/S1473-3099(14)70734-0. [DOI] [PubMed] [Google Scholar]
- 2.Tristram S, Jacobs MR, Appelbaum PC. 2007. Antimicrobial resistance in Haemophilus influenzae. Clin Microbiol Rev 20:368–389. doi: 10.1128/CMR.00040-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR). 2019. Critically important antimicrobials for human medicine 6th revision 2018. Ranking of medically important antimicrobials for risk management of antimicrobial resistance due to non-human use. https://apps.who.int/iris/bitstream/handle/10665/312266/9789241515528-eng.pdf?ua=1.
- 4.Sykes RB, Matthew M, O'Callaghan CH. 1975. R-factor mediated beta-lactamase production by Haemophilus influenzae. J Med Microbiol 8:437–441. doi: 10.1099/00222615-8-3-437. [DOI] [PubMed] [Google Scholar]
- 5.Tristram SG, Pitout MJ, Forward K, Campbell S, Nichols S, Davidson RJ. 2008. Characterization of extended-spectrum beta-lactamase-producing isolates of Haemophilus parainfluenzae. J Antimicrob Chemother 61:509–514. doi: 10.1093/jac/dkm523. [DOI] [PubMed] [Google Scholar]
- 6.Søndergaard A, San Millan A, Santos-Lopez A, Nielsen SM, Gonzalez-Zorn B, Nørskov-Lauritsen N. 2012. Molecular organization of small plasmids bearing blaTEM-1 and conferring resistance to β-lactams in Haemophilus influenzae. Antimicrob Agents Chemother 56:4958–4960. doi: 10.1128/AAC.00408-12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Fleury C, Resman F, Rau J, Riesbeck K. 2014. Prevalence, distribution and transfer of small β-lactamase-containing plasmids in Swedish Haemophilus influenzae. J Antimicrob Chemother 69:1238–1242. doi: 10.1093/jac/dkt511. [DOI] [PubMed] [Google Scholar]
- 8.Juhas M, Dimopoulou I, Robinson E, Elamin A, Harding R, Hood D, Crook D. 2013. Identification of another module involved in the horizontal transfer of the Haemophilus genomic island ICEHin1056. Plasmid 70:277–283. doi: 10.1016/j.plasmid.2013.05.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Roberts MC, Swenson CD, Owens LM, Smith AL. 1980. Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother 18:610–615. doi: 10.1128/aac.18.4.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Chopra I, Roberts M. 2001. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev 65:232–260. doi: 10.1128/MMBR.65.2.232-260.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vik E, Rusten L, Falk ES, Melby K. 1986. Multiresistent Haemophilus influenzae. Tidsskr nor Laegeforen 106:1119–1120. (In Norwegian.) [PubMed] [Google Scholar]
- 12.Guglielmini J, Quintais L, Garcillán-Barcia MP, de la Cruz F, Rocha E. 2011. The repertoire of ICE in prokaryotes underscores the unity, diversity, and ubiquity of conjugation. PLoS Genet 7:e1002222. doi: 10.1371/journal.pgen.1002222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Wozniak RA, Waldor MK. 2010. Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat Rev Microbiol 8:552–563. doi: 10.1038/nrmicro2382. [DOI] [PubMed] [Google Scholar]
- 14.Juhas M. 2015. Type IV secretion systems and genomic islands-mediated horizontal gene transfer in Pseudomonas and Haemophilus. Microbiol Res 170:10–17. doi: 10.1016/j.micres.2014.06.007. [DOI] [PubMed] [Google Scholar]
- 15.Juhas M, Crook DW, Dimopoulou ID, Lunter G, Harding RM, Ferguson DJP, Hood DW. 2007. Novel type IV secretion system involved in propagation of genomic islands. J Bacteriol 189:761–771. doi: 10.1128/JB.01327-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Cabezón E, Ripoll-Rozada J, Peña A, de la Cruz F, Arechaga I. 2015. Towards an integrated model of bacterial conjugation. FEMS Microbiol Rev 39:81–95. doi: 10.1111/1574-6976.12085. [DOI] [PubMed] [Google Scholar]
- 17.Ubukata K, Shibasaki Y, Yamamoto K, Chiba N, Hasegawa K, Takeuchi Y, Sunakawa K, Inoue M, Konno M. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob Agents Chemother 45:1693–1699. doi: 10.1128/AAC.45.6.1693-1699.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Osaki Y, Sanbongi Y, Ishikawa M, Kataoka H, Suzuki T, Maeda K, Ida T. 2005. Genetic approach to study the relationship between penicillin-binding protein 3 mutations and Haemophilus influenzae beta-lactam resistance by using site-directed mutagenesis and gene recombinants. Antimicrob Agents Chemother 49:2834–2839. doi: 10.1128/AAC.49.7.2834-2839.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.García-Cobos S, Campos J, Lázaro E, Román F, Cercenado E, García-Rey C, Pérez-Vázquez M, Oteo J, de Abajo F. 2007. Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51:2564–2573. doi: 10.1128/AAC.00354-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Skaare D, Anthonisen IL, Kahlmeter G, Matuschek E, Natås OB, Steinbakk M, Sundsfjord A. 2014. Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. Euro Surveill 19:20986. doi: 10.2807/1560-7917.es2014.19.49.20986. [DOI] [PubMed] [Google Scholar]
- 21.Takahata S, Ida T, Senju N, Sanbongi Y, Miyata A, Maebashi K, Hoshiko S. 2007. Horizontal gene transfer of ftsI, encoding penicillin-binding protein 3, in Haemophilus influenzae. Antimicrob Agents Chemother 51:1589–1595. doi: 10.1128/AAC.01545-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Søndergaard A, Witherden EA, Nørskov-Lauritsen N, Tristram SG. 2015. Interspecies transfer of the penicillin-binding protein 3-encoding gene ftsI between Haemophilus influenzae and Haemophilus haemolyticus can confer reduced susceptibility to β-lactam antimicrobial agents. Antimicrob Agents Chemother 59:4339–4342. doi: 10.1128/AAC.04854-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Witherden EA, Bajanca-Lavado MP, Tristram SG, Nunes A. 2014. Role of inter-species recombination of the ftsI gene in the dissemination of altered penicillin-binding-protein-3-mediated resistance in Haemophilus influenzae and Haemophilus haemolyticus. J Antimicrob Chemother 69:1501–1509. doi: 10.1093/jac/dku022. [DOI] [PubMed] [Google Scholar]
- 24.Skaare D, Anthonisen IL, Caugant DA, Jenkins A, Steinbakk M, Strand L, Sundsfjord A, Tveten Y, Kristiansen B-E. 2014. Multilocus sequence typing and ftsI sequencing: a powerful tool for surveillance of penicillin-binding protein 3-mediated beta-lactam resistance in nontypeable Haemophilus influenzae. BMC Microbiol 14:131. doi: 10.1186/1471-2180-14-131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Mizoguchi A, Hitomi S. 2019. Cefotaxime-non-susceptibility of Haemophilus influenzae induced by additional amino acid substitutions of G555E and Y557H in altered penicillin-binding protein 3. J Infect Chemother 25:509–513. doi: 10.1016/j.jiac.2019.02.010. [DOI] [PubMed] [Google Scholar]
- 26.Maughan H, Redfield RJ. 2009. Extensive variation in nautral competence in Haemophilus influenzae. Evolution 63:1852–1866. doi: 10.1111/j.1558-5646.2009.00658.x. [DOI] [PubMed] [Google Scholar]
- 27.Mell JC, Hall IM, Redfield RJ. 2012. Defining the DNA uptake specificity of naturally competent Haemophilus influenzae cells. Nucleic Acids Res 40:8536–8549. doi: 10.1093/nar/gks640. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.de Groot R, Sluijter M, de Bruyn A, Campos J, Goessens WH, Smith AL, Hermans PW. 1996. Genetic characterization of trimethoprim resistance in Haemophilus influenzae. Antimicrob Agents Chemother 40:2131–2136. doi: 10.1128/AAC.40.9.2131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Enne VI, King A, Livermore DM, Hall L. 2002. Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folP. Antimicrob Agents Chemother 46:1934–1939. doi: 10.1128/aac.46.6.1934-1939.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Georgiou M, Muñoz R, Román F, Cantón R, Gómez-Lus R, Campos J, De La Campa AG. 1996. Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother 40:1741–1744. doi: 10.1128/AAC.40.7.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kuo S-C, Chen P-C, Shiau Y-R, Wang H-Y, Lai J-F, Huang W, Lauderdale T-L. 2014. Levofloxacin-resistant Haemophilus influenzae, Taiwan, 2004–2010. Emerg Infect Dis 20:1386–1390. doi: 10.3201/eid2008.140341. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bi D, Liu L, Tai C, Deng Z, Rajakumar K, Ou HY. 2013. SecReT4: a web-based bacterial type IV secretion system resource. Nucleic Acids Res 41:D660–D665. doi: 10.1093/nar/gks1248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Juhas M, Power PM, Harding RM, Ferguson DJP, Dimopoulou ID, Elamin ARE, Mohd-Zain Z, Hood DW, Adegbola R, Erwin A, Smith A, Munson RS, Harrison A, Mansfield L, Bentley S, Crook DW. 2007. Sequence and functional analyses of Haemophilus spp. genomic islands. Genome Biol 8:R237. doi: 10.1186/gb-2007-8-11-r237. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Dy RL, Przybilski R, Semeijn K, Salmond GPC, Fineran PC. 2014. A widespread bacteriophage abortive infection system functions through a type IV toxin-antitoxin mechanism. Nucleic Acids Res 42:4590–4605. doi: 10.1093/nar/gkt1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Mohd-Zain Z, Turner SL, Cerdeño-Tárraga AM, Lilley AK, Inzana TJ, Duncan AJ, Harding RM, Hood DW, Peto TE, Crook DW. 2004. Transferable antibiotic resistance elements in Haemophilus influenzae share a common evolutionary origin with a diverse family of syntenic genomic islands. J Bacteriol 186:8114–8122. doi: 10.1128/JB.186.23.8114-8122.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tock MR, Dryden D. 2005. The biology of restriction and anti-restriction. Curr Opin Microbiol 8:466–472. doi: 10.1016/j.mib.2005.06.003. [DOI] [PubMed] [Google Scholar]
- 37.Kalman M, Gentry DR, Cashel M. 1991. Characterization of the Escherichia coli K12 gltS glutamate permease gene. Mol Gen Genet 225:379–386. doi: 10.1007/bf00261677. [DOI] [PubMed] [Google Scholar]
- 38.Ubukata K. 2003. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. J Infect Chemother 9:285–291. doi: 10.1007/s10156-003-0278-y. [DOI] [PubMed] [Google Scholar]
- 39.Roberts MC, Soge OO, No DB. 2011. Characterization of macrolide resistance genes in Haemophilus influenzae isolated from children with cystic fibrosis. J Antimicrob Chemother 66:100–104. doi: 10.1093/jac/dkq425. [DOI] [PubMed] [Google Scholar]
- 40.Pfeifer Y, Meisinger I, Brechtel K, Gröbner S. 2013. Emergence of a multi-drug resistant Haemophilus influenzae causing chronic pneumonia in a patient with common variable immunodeficiency. Microb Drug Resist 19:1–5. doi: 10.1089/mdr.2012.0060. [DOI] [PubMed] [Google Scholar]
- 41.Gomez-Lus R, Vergara Y. 1995. Aminoglycoside Resistance in Haemophilus influenzae. J Chemother 7:97–99. doi: 10.1179/joc.1995.7.2.97. [DOI] [PubMed] [Google Scholar]
- 42.Soge OO, Roberts MC. 2011. tet(M)-carrying Haemophilus influenzae as a potential reservoir for mobile antibiotic resistance genes. J Antimicrob Chemother 66:1642–1643. doi: 10.1093/jac/dkr189. [DOI] [PubMed] [Google Scholar]
- 43.Kitaoka K, Kimura K, Kitanaka H, Banno H, Jin W, Wachino J-I, Arakawa Y. 2018. Carbapenem-nonsusceptible Haemophilus influenzae with penicillin-binding protein 3 containing an amino acid insertion. Antimicrob Agents Chemother 62:e00671-18. doi: 10.1128/AAC.00671-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.European Committee on Antimicrobial Susceptibility Testing. 2019. Breakpoint tables for interpretation of MICs and zone diameters, version 9.0, 2019. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_9.0_Breakpoint_Tables.pdf.
- 45.European Committee on Antimicrobial Susceptibility Testing. 2019. MIC determination of non-fastidious and fastidious organisms. http://www.eucast.org/ast_of_bacteria/mic_determination/?no_cache=1.
- 46.Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30:2114–2120. doi: 10.1093/bioinformatics/btu170. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi: 10.1089/cmb.2012.0021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, Jelsbak L, Sicheritz-Pontén T, Ussery DW, Aarestrup FM, Lund O. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 50:1355–1361. doi: 10.1128/JCM.06094-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Treangen TJ, Ondov BD, Koren S, Phillippy AM. 2014. The Harvest suite for rapid core-genome alignment and visualization of thousands of intraspecific microbial genomes. Genome Biol 15:524. doi: 10.1186/s13059-014-0524-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.De Chiara M, Hood D, Muzzi a, Pickard DJ, Perkins T, Pizza M, Dougan G, Rappuoli R, Moxon ER, Soriani M, Donati C. 2014. Genome sequencing of disease and carriage isolates of nontypeable Haemophilus influenzae identifies discrete population structure. Proc Natl Acad Sci U S A 111:5439–5444. doi: 10.1073/pnas.1403353111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Price MN, Dehal PS, Arkin AP. 2010. FastTree 2–approximately maximum-likelihood trees for large alignments. PLoS One 5:e9490. doi: 10.1371/journal.pone.0009490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009–1010. doi: 10.1093/bioinformatics/btr039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Fleischmann RD, Adams MD, White O, Clayton RA, Kirkness EF, Kerlavage AR, Bult CJ, Tomb JF, Dougherty BA, Merrick JM. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496–512. doi: 10.1126/science.7542800. [DOI] [PubMed] [Google Scholar]
- 54.Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. doi: 10.1093/jac/dks261. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Carver T, Berriman M, Tivey A, Patel C, Böhme U, Barrell BG, Parkhill J, Rajandream M-A. 2008. Artemis and ACT: viewing, annotating and comparing sequences stored in a relational database. Bioinformatics 24:2672–2676. doi: 10.1093/bioinformatics/btn529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421. doi: 10.1186/1471-2105-10-421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi: 10.1093/bioinformatics/btu153. [DOI] [PubMed] [Google Scholar]
- 58.Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group. 2007. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway. J Clin Microbiol 45:199–205. doi: 10.1128/JCM.01319-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The whole-genome sequences of the isolates have been deposited in GenBank under BioProject number PRJNA557131. The novel ICE element sequences have been deposited in GenBank under the accession numbers MN106410 to MN106412.